AW Healthcare Beat: Private equity, hedge funds back gene therapy promise

RNA-based therapies and data platforms geared toward oncology treatment are among the deals done in this week’s installment of the Alts Watch Healthcare Beat.

The partnership, two PIPEs and other financing deals totaled over $500 million, according to our tally of all financing deals of $40 million-plus for the week ending February 7.

Leading investors were hedge fund firms Adage Capital and Farallon Capital as well as Surveyor Capital, a unit of . . .

Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.

Get started

Back to top button

Start Your Days in the Know

 

Get fresh alts intel in your inbox with our FREE newsletter!

You have Successfully Subscribed!